News
MIR
9.94
-2.55%
-0.26
Is Mirion Technologies (NYSE:MIR) Using Too Much Debt?
Mirion Technologies, Inc. Has US$685.4m of debt. The company uses debt in its business to fund growth. Mirion Technologies has a balance sheet of US$565.2m. The balance sheet is a good place to look at a company's ability to pay off debt. However, the future profitability of the business will determine Mirion's risk. We have identified 1 warning sign for Mirion.
Simply Wall St · 1d ago
Mirion Technologies' Quarterly Report on Form 10-Q: Business Combination and Financial Results
Press release · 2d ago
MIR Stock Earnings: Mirion Technologies Meets EPS, Beats Revenue for Q1 2024
Mirion Technologies reported earnings per share of 6 cents for the first quarter of 2024. The company reported revenue of $192.60 million. This was 0.65% better than the analyst estimate of $191.35 million. Mirion Technologies also reported results for the fourth quarter of 2015.
Investorplace · 2d ago
Mirion Technologies Q1 2024 GAAP EPS $0.06, Inline, Sales $192.600M Beat $191.355M Estimate
Mirion Technologies reported quarterly earnings of $0.06 per share which met the analyst consensus estimate. The company reported quarterly sales of $192.600 million which is up 5.77 percent from the same period last year. Mirion Technologies also beat the sales estimate of $191.355 million.
Benzinga · 2d ago
*Mirion Technologies Continues to Expect FY24 Rev Growth of 5% to 7%
Dow Jones · 2d ago
*Mirion Technologies 1Q Rev $192.6M >MIR
Dow Jones · 2d ago
*Mirion Technologies 1Q Loss/Shr 13c >MIR
Dow Jones · 2d ago
Weekly Report: what happened at MIR last week (0422-0426)?
Weekly Report · 4d ago
Weekly Report: what happened at MIR last week (0415-0419)?
Weekly Report · 04/22 09:29
MIRION TECHNOLOGIES INC - REDEMPTION OF PUBLIC WARRANTS FOR A REDEMPTION PRICE OF $0.10 PER WARRANT
Reuters · 04/18 10:30
Mirion Announces Redemption of Public Warrants
Mirion will redeem all of its publicly traded warrants to purchase shares of Class A common stock for a redemption price of $0.10 per warrant. Warrant holders may continue to exercise their warrants until May 20, 2024. Mirion is a global provider of radiation detection, measurement and monitoring solutions.
Barchart · 04/18 05:30
Press Release: Mirion Announces Earnings Release and Conference Call Date for First Quarter 2024
Mirion will release financial results for first quarter 2024 after market close on April 30, 2024. The company will host a conference call the next day, May 1, 2024, to discuss the results. Mirion is a global leader in radiation safety, science and medicine.
Dow Jones · 04/17 12:35
Weekly Report: what happened at MIR last week (0408-0412)?
Weekly Report · 04/15 09:26
Mirion Technologies Is Maintained at Buy by Citigroup
Dow Jones · 04/08 22:33
Mirion Technologies Price Target Raised to $14.00/Share From $13.00 by Citigroup
Dow Jones · 04/08 22:33
Citigroup Maintains Buy on Mirion Technologies, Raises Price Target to $14
Benzinga · 04/08 22:23
Weekly Report: what happened at MIR last week (0401-0405)?
Weekly Report · 04/08 09:28
Is Mirion Technologies, Inc. (NYSE:MIR) Potentially Undervalued?
Mirion Technologies, Inc. Saw a double-digit share price rise of over 10% in the past few months. The company is currently trading around its 52-week high. Mirion Technologies is overvalued by 21% compared to its intrinsic value. However, the company has a positive outlook and is expected to grow in the future. Could the stock still be trading at a relatively cheap price? We look at the company's valuation and outlook.
Simply Wall St · 04/05 14:08
Mirion Technologies Inc: Statement of changes in beneficial ownership of securities
Press release · 04/02 06:18
Weekly Report: what happened at MIR last week (0325-0329)?
Weekly Report · 04/01 09:28
More
Webull provides a variety of real-time MIR stock news. You can receive the latest news about Mirion Technologies Inc through multiple platforms. This information may help you make smarter investment decisions.
About MIR
Mirion Technologies, Inc. is a global provider of radiation detection, measurement, analysis and monitoring solutions to the medical, nuclear, defense, and research end markets. The Company's segments include Medical and Technologies. The Medical segment includes products and services for radiation therapy and personal dosimetry. This segment's offerings include solutions for calibrating and/or verifying imaging, treatment machine, patient treatment plan, and patient treatment accuracy; solutions for monitoring the total amount of radiation medical staff members are exposed to over time, and products for nuclear medicine in radiation measurement, shielding, product handling, medical imaging furniture and rehabilitation. The Technologies segment includes products and services for defense, nuclear energy, laboratories and research and other industrial markets. This segment's offerings include reactor safety and control systems, and radiological search, measurement and analysis systems.